We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$32.6B
AUM Growth
+$5.94B
(+22%)
Cap. Flow
+$4.68B
Cap. Flow
% of AUM
14.35%
Top 10 Holdings %
Top 10 Hldgs %
28.49%
Holding
5,277
New
882
Increased
1,986
Reduced
1,465
Closed
789
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$136M |
| 3 |
Boston Scientific
BSX
|
+$125M |
| 4 |
Intuitive Surgical
ISRG
|
+$81.6M |
| 5 |
Applied Materials
AMAT
|
+$66.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$248M |
| 2 |
NVIDIA
NVDA
|
+$246M |
| 3 |
Tesla
TSLA
|
+$236M |
| 4 |
Broadcom
AVGO
|
+$209M |
| 5 |
Palantir
PLTR
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.32% |
| 2 | Healthcare | 7.04% |
| 3 | Consumer Discretionary | 5.39% |
| 4 | Industrials | 4.55% |
| 5 | Financials | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
Tyson Foods
TSN
$21.5B
| $40.1K | ﹤0.01% |
684
-175,050
| -100% | -$9.61M |
|
4077
Aramark
ARMK
$15B
| $40K | ﹤0.01% |
+1,086
| New | +$41.4K |
|
4078
PUT
Charles River Laboratories
CRL
$11.3B
| $39.9K | ﹤0.01% |
200
-5,000
| -96% | -$907K |
|
4079
PUT
Core Scientific
CORZ
$5.82B
| $39.3K | ﹤0.01% |
2,700
-29,400
| -92% | -$513K |
|
|
XIFR
4080
CALL
XPLR Infrastructure LP
XIFR
$1.04B
| $39K | ﹤0.01% |
3,900
-2,000
| -34% | -$19.4K |
|
4081
PUT
Rockwell Automation
ROK
$51.1B
| $38.9K | ﹤0.01% |
+100
| New | +$37.6K |
|
4082
Kura Oncology
KURA
$793M
| $38.9K | ﹤0.01% |
+3,742
| New | +$39.3K |
|
4083
CALL
Insperity
NSP
$2.03B
| $38.7K | ﹤0.01% |
1,000
-3,300
| -77% | -$132K |
|
|
NGD
4084
DELISTED
New Gold Inc
NGD
| $38.3K | ﹤0.01% |
4,398
-1,854,374
| -100% | -$14M |
|
4085
PUT
Ryder
R
$9.9B
| $38.3K | ﹤0.01% |
200
-200
| -50% | -$35.9K |
|
4086
CALL
Neumora Therapeutics
NMRA
$306M
| $38.1K | ﹤0.01% |
+21,300
| New | +$46.6K |
|
4087
Petco
WOOF
$797M
| $38K | ﹤0.01% |
+13,529
| New | +$43.8K |
|
4088
PUT
Domo
DOMO
$171M
| $37.9K | ﹤0.01% |
4,500
-23,400
| -84% | -$275K |
|
|
BLSH
4089
PUT
Bullish
BLSH
$3.31B
| $37.9K | ﹤0.01% |
+1,000
| New | +$48.7K |
|
4090
CALL
Pacific Biosciences
PACB
$435M
| $37.4K | ﹤0.01% |
+20,000
| New | +$38.4K |
|
4091
PUT
Criteo S.A. Ordinary Shares
CRTO
$1.14B
| $37.1K | ﹤0.01% |
+1,800
| New | +$37.2K |
|
4092
Beam Therapeutics
BEAM
$2.68B
| $37.1K | ﹤0.01% |
+1,338
| New | +$34.1K |
|
4093
PUT
Inspire Medical Systems
INSP
$1.47B
| $36.9K | ﹤0.01% |
400
-2,100
| -84% | -$201K |
|
|
VTYX
4094
DELISTED
Ventyx Biosciences
VTYX
| $36.8K | ﹤0.01% |
4,080
-181,385
| -98% | -$1.36M |
|
4095
PUT
ReNew
RNW
$2.18B
| $36.7K | ﹤0.01% |
6,500
| – | – |
|
4096
CALL
Mercury Systems
MRCY
$5.41B
| $36.5K | ﹤0.01% |
+500
| New | +$37.2K |
|
4097
Best Buy
BBY
$19B
| $36.2K | ﹤0.01% |
541
-384,960
| -100% | -$29.4M |
|
|
BLDP
4098
PUT
Ballard Power Systems
BLDP
$754M
| $36.1K | ﹤0.01% |
+14,200
| New | +$44K |
|
4099
Health Catalyst
HCAT
$160M
| $35.6K | ﹤0.01% |
14,910
-611
| -4% | -$1.67K |
|
4100
PUT
iRhythm Holdings
IRTC
$4.02B
| $35.5K | ﹤0.01% |
200
-100
| -33% | -$17.7K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Walleye Capital held 5,277 positions worth $32.6B, up 22% from $26.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Walleye Capital deployed $4.68B of net new capital in Q4 2025, opening 882 new positions and adding to 1,986 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 6,616,070 shares worth $4.53B.
By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $248M trimmed.
- Walleye Capital's largest Q4 2025 buy was iShares Core S&P 500 ETF: 6,616,070 shares worth $4.53B.
- Walleye Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $136M increase.
- Walleye Capital's biggest Q4 2025 reduction was Apple, cutting an estimated $248M.
- Walleye Capital fully exited Mohawk Industries in Q4 2025, selling an estimated $39.8M.
- Walleye Capital's ten largest holdings make up 28% of its $32.6B portfolio in Q4 2025.
- Walleye Capital opened 882 new positions and closed 789 in Q4 2025.
- Walleye Capital's portfolio value rose 22% quarter-over-quarter to $32.6B.
Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.